TTD Drug ID: DAP000322

Drug Information
Name	Clemastine
Synonyms	NCGC00016710-01; Clemastine [USAN:BAN]; Tavegyl; HS 592; 14976-57-9; Spectrum2_000689; Prestwick2_000306; AC1L1CAE; Clemastina; IDI1_000285; KBio1_000285; NINDS_000285; HMS2089I22; Spectrum3_000353; C21H26ClNO; Prestwick1_000306; (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine; (2R)-2-(2-{[(1R)-1-(4-chlorophenyl)-1-phenylethyl]oxy}ethyl)-1-methylpyrrolidine; CHEBI:3738; NCGC00015281-01; BSPBio_002045; clemastine; Clemastinum [INN-Latin]; Prestwick0_000306; Mecloprodin; (+)-(2R)-2-[2-[[(R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine; Meclastine; DB00283; BSPBio_000272; SPBio_000817; (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine; KBioGR_001570; 15686-51-8; Spectrum5_001520; BPBio1_000300; 2(R)-[2-[(1R)-(4-Chlorophenyl)-1-phenyl-ethoxy]ethyl-1-methylpyrrolidine; Clemastinum; Lopac-C-8903; Meclastin; HS-592; (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine; CAS-14976-57-9; UNII-95QN29S1ID; CID26987; BRD-K30240666-051-05-0; AC1Q3N52; CLEMASTINE FUMARATE; BIDD:GT0391; SPBio_002491; CHEMBL1626; Clemastina [INN-Spanish]; Spectrum4_000955; LS-137531; DivK1c_000285; Tavist (*Fumarate*); Tocris-1453; Tavist; 2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin; NCGC00025168-01; Prestwick3_000306; KBio3_001265
Trade Name	Tavist; Tavegyl
Company	Norvatis Phamaceuticals Corporation
Indication	Allergic rhinitis			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Anti-Allergic Agents
CAS Number	CAS 15686-51-8
Formular	C21H26ClNO
PubChem Compound ID	CID 26987.
PubChem Substance ID	SID 205033.
SuperDrug ATC ID	D04AA14;
SuperDrug CAS ID	015686518;
Target	Histamine H1 receptor			Antagonist	[2][3]
Ref 1	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 073283 To Reference
Ref 2	Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol. 2008 Dec;128(12):2783-91. Epub 2008 Jun 12. To Reference
Ref 3	Stereoselective synthesis of (-)-hydroxyclemastine as a versatile intermediate for the H1 receptor antagonist clemastine. Arch Pharm Res. 2007 Dec;30(12):1521-5. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.